COVID-19: Analysis of the Emerging Disease Landscape - March 2020

COVID-19: Analysis of the Emerging Disease Landscape - March 2020

Summary

The epidemiology of COVID-19 is rapidly evolving and a number of companies have begun to invest in this space. The absence of proven therapeutic options and the lack of a vaccine to protect against infection has led to a race to develop effective interventions. A range of players - from pharma and biotech firms to academic institutions and government agencies - have thrown their hats in the ring.

Scope

  • Global epidemiology metrics and trends
  • Snapshot of epidemiological trends to date in the top three most-affected countries
  • An overview of the pipeline for antivirals and vaccines
  • Summary of available efficacy data
  • An assessment of the clinical trials landscape by phase, sponsor type, geography, and other key attributes
  • Highlights in deal-making trends, particularly public-private partnerships
  • Spotlight on social media coverage
Reasons to Buy
  • Global epidemiology metrics and trends
  • Snapshot of epidemiological trends to date in the top three most-affected countries
  • An overview of the pipeline for antivirals and vaccines
  • Summary of available efficacy data
  • An assessment of the clinical trials landscape by phase, sponsor type, geography, and other key attributes
  • Highlights in deal-making trends, particularly public-private partnerships
  • Spotlight on social media coverage


  • Executive Summary
    • Report Scope
    • Navigate the COVID- Outbreak with GlobalData Pharma's COVID- Dashboard
    • Monitor the COVID- Outbreak with GlobalData Epidemiology Indicators
  • Disease Background
  • Disease Background: Coronaviruses
    • Disease Background: COVID-19
  • Epidemiology
    • Epidemiology: Snapshot as of March 25,2020
      • Table Total Confirmed Cases in the Top Ten Countries
    • Epidemiology: Disease Trajectory as of March 25,2020
    • Epidemiology Indicators in the Top Three Most-Affected Countries: Disease Trajectory in China as of March 25,2020
    • Epidemiology Indicators in the Top Three Most-Affected Countries: Disease Trajectory in Italy as of March 25,2020
    • Epidemiology Indicators in the Top Three Most-Affected Countries: Disease Trajectory in the US as of March 25,2020
    • Epidemiology Forecast: United States
  • Pipeline Overview
    • Pipeline Therapeutics: Breakdown by Phase
    • Pipeline Therapeutics: Breakdown by Molecule Type
    • Pipeline Therapeutics: Breakdown by Type of Developer
    • Pipeline Therapeutics: Clinical-Stage Candidates (Phase I-III)
    • Pipeline Therapeutics: Preclinical-Stage Candidates
    • Pipeline Therapeutics: Currently Available Data
    • Pipeline Vaccines: Breakdown by Phase
    • Pipeline Vaccines: Breakdown by Developer Type
    • Pipeline Vaccines: Clinical- and Preclinical-Stage Candidates
  • Clinical Trials
    • Clinical Trials: Breakdown by Phase
    • Clinical Trials: Breakdown by Status
    • Clinical Trials: Overview by Region
    • Clinical Trials for Therapeutics: Leading Sponsors
    • Clinical Trials: Leading Industry Sponsors
    • Trends in Trial Design
  • Deal-Making Trends
  • Social Media Trends
    • Key Twitter Chatter
    • Top Trending Tweets include #Covid #Coronavirus #Patients #Flattenthecurve
  • Key Findings
  • Appendix
    • Sources
    • Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook